PD-1inhibitor Clinical Trials
3 recruitingDrug
Phase 11Phase 21Phase 31
Showing 1–3 of 3 trials
Recruiting
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled1 locationNCT06417892
Recruiting
Phase 1Phase 2
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital50 enrolled1 locationNCT06173986
Recruiting
Phase 3
PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy
HNSCCRadiotherapyPD-1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University324 enrolled1 locationNCT05980715